Lansoprazole 15 mg placebo

DRUG3 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

Healed Erosive EsophagitisNSAID (Non-Steroidal Anti-Inflammatory Drug)Peptic Ulcer

Phase 3

Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Daewoong Pharmaceutical Co. LTD.Healed Erosive Esophagitis

Start: 2020-07-02End: 2021-12-30Target: 406Updated: 2020-09-03

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

CompletedNCT04784910

Daewoong Pharmaceutical Co. LTD.Peptic Ulcer

Start: 2021-05-21End: 2023-12-11Updated: 2024-07-08

Phase 4

Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer

Not yet recruitingNCT07533266

Daewoong Pharmaceutical Co. LTD.NSAID (Non-Steroidal Anti-Inflammatory Drug)

Start: 2026-04-01End: 2027-12-01Target: 360Updated: 2026-04-16

Related Papers

Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer

Gut and Liver2025-06-262 citations